Browsing: Johnson & Johnson
The market wants a Federal Reserve interest-rate cut soon, but it doesn’t want to need one. Wall Street economists are…
A week removed from a brutal payroll report that triggered worry over a tapped consumer and a trapped Federal Reserve,…
CNBC’s Jim Cramer on Friday told investors what to follow next week as earnings season kicks off, highlighting reports from…
CNBC’s Jim Cramer reviewed why certain stocks that are usually considered safe bets — like pharmaceuticals or consumer packaged goods…
Goldman Sachs named pharmaceutical giant Johnson & Johnson to its “U.S. Conviction List – Directors’ Cut” of the most recommended…